Publications by authors named "Jacques Borger"

Claim this Profile
S
Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy.
Patricia J A M Brouwers, Tim Lustberg, Jacques H Borger, Angela A W van Baardwijk, Jos J Jager

Pract Radiat Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making.
Cary Oberije, Georgi Nalbantov, Andre Dekker, Liesbeth Boersma, Jacques Borger

Radiother Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid decline of follicular lymphoma-associated chylothorax after low dose radiotherapy to retroperitoneal lymphoma localization.
Lien Van De Voorde, Ben Vanneste, Jacques Borger, Esther G C Troost, Philo Werner

Case Rep Hematol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR).
Bart Reymen, Angela van Baardwijk, Rinus Wanders, Jacques Borger, Anne-Marie C Dingemans

Radiother Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
Bart Reymen, Judith Van Loon, Angela van Baardwijk, Rinus Wanders, Jacques Borger

Int J Radiat Oncol Biol Phys· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer.
Angela van Baardwijk, Bart Reymen, Stofferinus Wanders, Jacques Borger, Michel Ollers

Eur J Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study.
Dirk De Ruysscher, Angela van Baardwijk, Jessie Steevens, Anita Botterweck, Geert Bosmans, Jacques Borger

Radiother Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forward intensity-modulated radiotherapy planning in breast cancer to improve dose homogeneity: feasibility of class solutions.
Heike Peulen, Bianca Hanbeukers, Liesbeth Boersma, Angela van Baardwijk, Piet van den Ende, Jacques Borger

Int J Radiat Oncol Biol Phys· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
Rinus Wanders, Jessie Steevens, Anita Botterweck, Anne-Marie C Dingemans, Bart Reymen, Jacques Borger

Eur J Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is contrast enhancement required to visualize a known breast tumor in a pre-operative CT scan?
Liesbeth J Boersma, Bianca Hanbeukers, Carla Boetes, Jacques Borger, Piet van den Ende

Radiother Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of FDG-PET to target tumors by radiotherapy.
Guido Lammering, Dirk De Ruysscher, Angela van Baardwijk, Brigitta G Baumert, Jacques Borger

Strahlenther Onkol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.
Angela van Baardwijk, Stofferinus Wanders, Liesbeth Boersma, Jacques Borger, Michel Ollers

J Clin Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.
Dirk De Ruysscher, Cary Dehing, Søren M Bentzen, Ruud Houben, André Dekker, Jacques Borger

Radiother Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Customized computed tomography-based boost volumes in breast-conserving therapy: use of three-dimensional histologic information for clinical target volume margins.
Bianca Hanbeukers, Jacques Borger, Piet van den Ende, Fred van der Ent, Ruud Houben

Int J Radiat Oncol Biol Phys· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.
Dirk De Ruysscher, Cary Dehing, Shipeng Yu, Rinus Wanders, Michel Ollers, Jacques Borger

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.
Dirk De Ruysscher, Ans Houben, Hugo J W L Aerts, Cary Dehing, Rinus Wanders, Jacques Borger

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.
Hugo J W L Aerts, Angela A W van Baardwijk, Steven F Petit, Claudia Offermann, Judith van Loon, Jacques Borger

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of skin markers and electronic portal imaging to improve verification of tangential breast irradiation.
Anke van der Salm, Jennifer Strijbos, Colette Dijcks, Lars Murrer, Jacques Borger

Radiother Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.
Bas Kreike, Augustinus A M Hart, Tony van de Velde, Jacques Borger, Hans Peterse

Int J Radiat Oncol Biol Phys· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer.
Jacques H Borger, Jørgen van den Bogaard, Daniëlle F M de Haas, Anna P B M Braeken, Lars H P Murrer

Radiother Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
Judith van Loon, Claudia Offermann, Geert Bosmans, Rinus Wanders, André Dekker, Jacques Borger

Radiother Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume.
Jacques H Borger, Maartje J Hooning, Liesbeth J Boersma, Antonia Snijders-Keilholz, Berthe M P Aleman

Int J Radiat Oncol Biol Phys· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prone breast irradiation for pendulous breasts.
Jeroen Buijsen, Jos J Jager, Janneke Bovendeerd, Robert Voncken, Jacques H Borger

Radiother Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
Coen W Hurkmans, Jacques H Borger, Emiel J Th Rutgers, Geertjan van Tienhoven,

Radiother Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy.
Bradley R Pieters, Augustinus A M Hart, Nicola S Russell, Edwin P M Jansen, Johannes L Peterse, Jacques Borger

Radiother Oncol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis